Humanizing the Treatment of Hyperactive Delirium in the Last Days of Life.
- 19 September 2017
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 318 (11), 1014-1015
- https://doi.org/10.1001/jama.2017.11466
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Delirium Frequency and Risk Factors Among Patients With Cancer in Palliative Care UnitAmerican Journal of Hospice and Palliative Medicine®, 2016
- Measuring delirium point-prevalence in two Australian palliative care inpatient unitsInternational Journal of Palliative Nursing, 2016
- A Systematic Review of Risk Factors for Delirium in the ICU*Critical Care Medicine, 2015
- Long-Term Cognitive Impairment after Critical IllnessThe New England Journal of Medicine, 2013
- Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trialThe Lancet Respiratory Medicine, 2013
- Point: Should Benzodiazepines be Avoided in Mechanically Ventilated Patients? YesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2012
- Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial*Critical Care Medicine, 2010
- A Systematic Review of Satisfaction with Care at the End of LifeJournal of the American Geriatrics Society, 2007
- Lorazepam Is an Independent Risk Factor for Transitioning to Delirium in Intensive Care Unit PatientsAnesthesiology, 2006
- The Delirium Experience: Delirium Recall and Delirium-Related Distress in Hospitalized Patients With Cancer, Their Spouses/Caregivers, and Their NursesPsychosomatics, 2002